Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lode J. Swinnen, MD
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
104 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Veterans Affairs Medical Center - Palo Alto
Palo Alto, California, United States
- Front Range Cancer Specialists
Fort Collins, Colorado, United States
- Baptist Cancer Institute - Jacksonville
Jacksonville, Florida, United States
- Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
- Rush-Copley Cancer Care Center
Aurora, Illinois, United States
- St. Joseph Medical Center
Bloomington, Illinois, United States
- Graham Hospital
Canton, Illinois, United States
- Memorial Hospital
Carthage, Illinois, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
- Eureka Community Hospital
Eureka, Illinois, United States
- Evanston Northwestern Healthcare - Evanston Hospital
Evanston, Illinois, United States
- Galesburg Clinic, Pc
Galesburg, Illinois, United States
- Galesburg Cottage Hospital
Galesburg, Illinois, United States
- Mason District Hospital
Havana, Illinois, United States
- Hinsdale Hematology Oncology Associates
Hinsdale, Illinois, United States
- Hopedale Medical Complex
Hopedale, Illinois, United States
- Joliet Oncology-Hematology Associates, Limited - West
Joliet, Illinois, United States
- Mcdonough District Hospital
Macomb, Illinois, United States
- Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
Moline, Illinois, United States
- Facility name not stated
Moline, Illinois, United States
- Bromenn Regional Medical Center
Normal, Illinois, United States
- Community Cancer Center
Normal, Illinois, United States
- Community Hospital of Ottawa
Ottawa, Illinois, United States
- Oncology Hematology Associates of Central Illinois, Pc - Ottawa
Ottawa, Illinois, United States
- Cancer Treatment Center at Pekin Hospital
Pekin, Illinois, United States
- Ccop - Illinois Oncology Research Association
Peoria, Illinois, United States
- Methodist Medical Center of Illinois
Peoria, Illinois, United States
- Osf St. Francis Medical Center
Peoria, Illinois, United States
- Oncology Hematology Associates of Central Illinois, Pc - Peoria
Peoria, Illinois, United States
- Proctor Hospital
Peoria, Illinois, United States
- Illinois Valley Community Hospital
Peru, Illinois, United States
- Perry Memorial Hospital
Princeton, Illinois, United States
- St. Margaret'S Hospital
Spring Valley, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Carle Cancer Center at Carle Foundation Hospital
Urbana, Illinois, United States
- Saint Anthony Memorial Health Centers
Michigan City, Indiana, United States
- Mcfarland Clinic, Pc
Ames, Iowa, United States
- Facility name not stated
Bettendorf, Iowa, United States
- Ccop - Iowa Oncology Research Association
Des Moines, Iowa, United States
- John Stoddard Cancer Center at Iowa Lutheran Hospital
Des Moines, Iowa, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Sept 2006
- Primary completion
- 30 Jun 2013
- Completion
- 31 Mar 2019
- Last update posted
- 29 Jun 2023
- Registered enrollment
- 100
- Registry id
- NCT00274924
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.